Pharmaceutical compositions for the treatment of movement disorders
First Claim
Patent Images
1. A pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of a movement disorder comprising an NMDAR agonist or partial agonist as active ingredient therein in combination with a pharmaceutically acceptable carrier.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides a pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of a movement disorder comprising an NMDAR agonist or partial agonist as active ingredient therein in combination with a pharmaceutically acceptable carrier.
46 Citations
28 Claims
- 1. A pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of a movement disorder comprising an NMDAR agonist or partial agonist as active ingredient therein in combination with a pharmaceutically acceptable carrier.
-
5. Use of NMDAR agonists and partial agonists for the manufacture of a pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of movement disorders.
- 6. A method for the treatment of a movement disorder comprising administering to a patient a a therapeutically effective amount, for alleviating motor disorder symptoms, of an agonist or partial agonist of the glycine-site of an NMDA receptor.
-
27. A pharmaceutical composition for the treatment of a movement disorder comprising a prodrug of an NMDAR agonist or precursor thereof as active ingredient therein in combination with a pharmaceutically acceptable carrier.
-
28. A method for the treatment of a movement disorder comprising administering to a patient a therapeutically effective amount, for alleviating motor disorder symptoms, of a prodrug of an NMDAR agonist or precursor thereof.
Specification